UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug utilization in patients starting haemodialysis with a focus on cardiovascular and antidiabetic medications: an epidemiological study in the Lazio region (Italy), 2016-2020

BMC nephrology, 2024-03, Vol.25 (1), p.98-98, Article 98

2024

Volltextzugriff (PDF)

P1397LONG-TERM EFFICACY AND SAFETY OF ETELCALCETIDE IN HEMODIALYSIS PATIENTS WITH SEVERE SECONDARY HYPERPARATHYROIDISM

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

SP733CHOLECALCIFEROL SUPPLEMENTATION IMPROVES SECONDARY HYPERPARATHYROIDISM CONTROL IN RENAL TRANSPLANT PATIENTS

Nephrology, dialysis, transplantation, 2019-06, Vol.34 (Supplement_1)

2019

Volltextzugriff (PDF)

SP621EFFICACY AND SAFETY OF ETELCALCETIDE IN HEMODIALYSIS PATIENTS WITH SEVERE SECONDARY HYPERPARATHYROIDISM

Nephrology, dialysis, transplantation, 2019-06, Vol.34 (Supplement_1)

2019

Volltextzugriff (PDF)

FP358PARICALCITOL THERAPY IMPROVES LEFT VENTRICULAR HYPERTROPHY IN RENAL TRANSPLANT PATIENTS WITH SECONDARY HYPERPARATHYROIDISM

Nephrology, dialysis, transplantation, 2018-05, Vol.33 (suppl_1), p.i152-i152

2018

Volltextzugriff (PDF)

FP616CHOLECALCIFEROL SUPPLEMENTATION IMPROVES SECONDARY HYPERPARATHYROIDISM CONTROL IN HEMODIALYSIS PATIENTS

Nephrology, dialysis, transplantation, 2018-05, Vol.33 (suppl_1), p.i249-i250

2018

Volltextzugriff (PDF)

MP793B-TYPE NATRIURETIC PEPTIDE LEVELS ARE ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY IN RENAL TRANSPLANT RECIPIENTS

Nephrology, dialysis, transplantation, 2017-05, Vol.32 (suppl_3), p.iii725-iii725

2017

Volltextzugriff (PDF)

SP384LONG-TERM EFFICACY OF CINACALCET IN THE TREATMENT OF PERSISTENT HYPERCALCEMIC HYPERPARATHYROIDISM IN RENAL TRANSPLANT PATIENTS

Nephrology, dialysis, transplantation, 2017-05, Vol.32 (suppl_3), p.iii242-iii243

2017

Volltextzugriff (PDF)

SP675ASSOCIATION BETWEEN LOW SERUM MAGNESIUM LEVELS AND THE EXTENT OF ABDOMINAL AORTIC CALCIFICATION IN RENAL TRANSPLANT PATIENTS

Nephrology, dialysis, transplantation, 2016-05, Vol.31 (suppl_1), p.i319-i320

2016

Volltextzugriff (PDF)

SP790EFFECTIVENESS AND SAFETY OF ORAL PARICALCITOL ON LONG-TERM TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN KIDNEY TRANSPLANT PATIENTS

Nephrology, dialysis, transplantation, 2015-05, Vol.30 (suppl_3), p.iii639-iii639

2015

Volltextzugriff (PDF)

Calcifediol supplementation in adults on hemodialysis: a randomized controlled trial

Journal of nephrology, 2022-03, Vol.35 (2), p.517-525

2022

Volltextzugriff (PDF)

MP709CHANGES IN LEFT VENTRICULAR HYPERTROPHY AFTER RENAL TRANSPLANTATION

Nephrology, dialysis, transplantation, 2016-05, Vol.31 (suppl_1), p.i575-i575

2016

Volltextzugriff (PDF)

CKD-MBD management: what is the role of parathyroidectomy? Results from a nationwide survey in Italy

Journal of nephrology, 2018-08, Vol.31 (4), p.585-591

2018

Volltextzugriff (PDF)

Effects of secondary hyperparathyroidism treatment on hemoglobin levels and erythropoietin doses in hemodialysis patients

Journal of Clinical Nephrology, 2021-10, Vol.5 (3), p.88-94

2021

Volltextzugriff (PDF)

Cholecalciferol supplementation improves secondary hyperparathyroidism control in hemodialysis patients

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2020-06, Vol.37 (3)

2020

Volltextzugriff (PDF)

Multifaceted approach to a rare clinical case of calciphylaxis in a renal transplant recipient

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2019-09, Vol.36 (5)

2019

Volltextzugriff (PDF)

Treatment with ticlopidine is associated with reduction of cyclosporin a blood levels

Nephron (2015), 2002-09, Vol.92 (1), p.249-250

2002

Volltextzugriff (PDF)

Update 2017 of the KDIGO guidelines on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). What are the real changes?

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2018-05, Vol.35 (3)

2018

Volltextzugriff (PDF)

Parathormone and left ventricular hypertrophy

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2014-11, Vol.31 (6)

2014

Volltextzugriff (PDF)

Impact of Recombinant Human Erythropoietin Treatment on Left Ventricular Hypertrophy and Cardiac Function in Dialysis Patients

Blood purification, 1998, Vol.16 (6), p.317-324

1998

Volltextzugriff (PDF)

Sepsis-induced acute renal failure: unusual clinical presentation

Journal of nephrology, 1998-09, Vol.11 (5), p.261-265

1998

Volltextzugriff (PDF)

What can we learn from a statistically inconclusive trial? Consensus conference on the EVOLVE study results

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2013-09, Vol.30 (5)

2013

Volltextzugriff (PDF)

Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up

Kidney international, 1985-11, Vol.28 (5), p.783-790

1985

Volltextzugriff (PDF)

Effects of 1,25(OH)2D3 administration on serum bone GLA protein in predialysis chronic renal failure

Advances in experimental medicine and biology, 1986, Vol.208, p.297

1986

Volltextzugriff (PDF)

Circannual versus seasonal variations of longitudinally sampled 25-hydroxycholecalciferol serum levels

Biochemical medicine, 1984-08, Vol.32 (1), p.22-29

1984

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(49)

Sprache

Englisch
(46)
Italienisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drug utilization in patients starting haemodialysis with a focus on cardiovascular and antidiabetic medications: an epidemiological study in the Lazio region (Italy), 2016-2020

P1397LONG-TERM EFFICACY AND SAFETY OF ETELCALCETIDE IN HEMODIALYSIS PATIENTS WITH SEVERE SECONDARY HYPERPARATHYROIDISM

SP733CHOLECALCIFEROL SUPPLEMENTATION IMPROVES SECONDARY HYPERPARATHYROIDISM CONTROL IN RENAL TRANSPLANT PATIENTS

SP621EFFICACY AND SAFETY OF ETELCALCETIDE IN HEMODIALYSIS PATIENTS WITH SEVERE SECONDARY HYPERPARATHYROIDISM

FP358PARICALCITOL THERAPY IMPROVES LEFT VENTRICULAR HYPERTROPHY IN RENAL TRANSPLANT PATIENTS WITH SECONDARY HYPERPARATHYROIDISM

FP616CHOLECALCIFEROL SUPPLEMENTATION IMPROVES SECONDARY HYPERPARATHYROIDISM CONTROL IN HEMODIALYSIS PATIENTS

MP793B-TYPE NATRIURETIC PEPTIDE LEVELS ARE ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY IN RENAL TRANSPLANT RECIPIENTS

SP384LONG-TERM EFFICACY OF CINACALCET IN THE TREATMENT OF PERSISTENT HYPERCALCEMIC HYPERPARATHYROIDISM IN RENAL TRANSPLANT PATIENTS

SP675ASSOCIATION BETWEEN LOW SERUM MAGNESIUM LEVELS AND THE EXTENT OF ABDOMINAL AORTIC CALCIFICATION IN RENAL TRANSPLANT PATIENTS

SP790EFFECTIVENESS AND SAFETY OF ORAL PARICALCITOL ON LONG-TERM TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN KIDNEY TRANSPLANT PATIENTS

Calcifediol supplementation in adults on hemodialysis: a randomized controlled trial

MP709CHANGES IN LEFT VENTRICULAR HYPERTROPHY AFTER RENAL TRANSPLANTATION

CKD-MBD management: what is the role of parathyroidectomy? Results from a nationwide survey in Italy

Effects of secondary hyperparathyroidism treatment on hemoglobin levels and erythropoietin doses in hemodialysis patients

Cholecalciferol supplementation improves secondary hyperparathyroidism control in hemodialysis patients

Multifaceted approach to a rare clinical case of calciphylaxis in a renal transplant recipient

Treatment with ticlopidine is associated with reduction of cyclosporin a blood levels

Update 2017 of the KDIGO guidelines on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). What are the real changes?

Parathormone and left ventricular hypertrophy

Impact of Recombinant Human Erythropoietin Treatment on Left Ventricular Hypertrophy and Cardiac Function in Dialysis Patients

Sepsis-induced acute renal failure: unusual clinical presentation

What can we learn from a statistically inconclusive trial? Consensus conference on the EVOLVE study results

Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up

Effects of 1,25(OH)2D3 administration on serum bone GLA protein in predialysis chronic renal failure

Circannual versus seasonal variations of longitudinally sampled 25-hydroxycholecalciferol serum levels

Suchergebnisse filtern